Furthermore, the analysis of a cancer-associated genetic polymorphism in the CDH1 promoter uncovers a mechanism by which noncoding genetic variants influence epigenetic processes and affect functional elements in promoter–proximal transcripts by altering RNA secondary structure. The gene discussed is CDH1; the disease is cancer.